Shanghai Bono Biotechnology Co., Ltd. made its debut at the 4th BIONNOVA Beijing Innovation Forum, with booth D03 receiving much attention

>At the Beijing Innovation Forum, Bono Biotech, located at booth D03, had in-depth exchanges with industry pioneers, showcasing its innovative strength in the forefront of biopharmaceutical technology.

On September 23-24, 2025, the 4th BIONNOVA Beijing Innovation Forum was successfully held in Beijing. Shanghai Bono Biotechnology Co., Ltd., as an innovative enterprise in the field of biomedical instrument technology, made a brilliant appearance at booth D03 and had in-depth exchanges with numerous industry experts.

This forum is jointly supported by outstanding domestic and foreign enterprises such as Pfizer, Novo Nordisk, Shiyao Group, Legendary Biotech, Zaiding Pharmaceutical, and Tengshengbo Pharmaceutical, focusing on "full chain innovation collaboration and clinical demand docking". The forum gathers key forces from the upstream and downstream of the pharmaceutical industry, aiming to create a strong landing oriented Beijing industry exchange platform.

---

01 Forum Focus: Industry University Research Medical Investment Global Innovation Collision

This year's BIONNOVA Beijing Innovation Forum gathered over 90 guests from multinational pharmaceutical companies, local leaders Biotech、 Research institutes and frontline clinical institutions. The guest lineup covers the entire industry chain, reflecting the high professionalism and industry influence of the forum.

The forum has set up 17 special forums to discuss over 140 cutting-edge topics. The agenda closely follows the actual industry needs, focusing on key issues such as pipeline differentiation, international compliance pathways, and business strategy collaboration

Key areas such as antibody drugs, cell and gene therapy, small molecule innovative drugs, complex preparations, nucleic acid and peptide drugs, clinical and registration applications have become the focus of discussion. These issues reflect the current technological hotspots and development trends in the field of biomedicine.

02 On site direct strike: D03 booth precise docking promotes substantive cooperation

The forum gathered over 3000 innovative decision-makers on-site and held more than 240 one-on-one precision customized negotiations. The D03 booth of Shanghai Bono Biotechnology Co., Ltd. attracted a large number of professional visitors to stop and exchange ideas, becoming one of the popular booths on site.

The company representative at the conference stated, 'The professionalism of this forum exceeded expectations, and booth D03 provided us with a high-quality display platform.'. We not only had contact with potential partners, but also learned about trends, which is of great significance for us to formulate our next research and development strategy

The forum also set up an innovative technology enterprise exhibition area, where more than 100 innovative technology enterprises showcased their latest achievements. Among them, the D03 booth where Bono Biotech is located has become one of the focuses of attention for many attendees due to its professional display content.

03 Technological Frontier: Comprehensive Analysis of Biomedical Innovation Trends

The technology trends discussed at this forum reflect the latest developments in the field of biomedicine. From the perspective of agenda setting, the development of antibody drugs remains a focus of industry attention, especially for new antibodies such as bispecific antibodies.

Cell and gene therapy, as an emerging field, have attracted a lot of attention. The forum conducted in-depth discussions on technological breakthroughs, industrialization challenges, and regulatory policies in this field.

Innovative small molecule drugs, complex formulations, nucleic acid and peptide drugs are also key topics of the forum. The technological advancements in these fields are driving the pharmaceutical industry towards greater precision and efficiency.

04 Bono Participation: Technical Exhibition and Exchange Achievements at Booth D03

Shanghai Bono Biotechnology Co., Ltd. exchanged the latest research and development achievements in the field of biomedical instrument technology with peers at booth D03 through this forum. The company representative stated that the BIONNOVA forum has always been committed to building a 'dialogic, linkable, and convertible' platform for practitioners in the pharmaceutical industry. ”

Through the exhibition and exchange at booth D03, Bono Biotech not only demonstrated its technical strength, but also established preliminary contacts with potential customers and partners. This deep integration of industry, academia, and research in communication mode helps promote technological innovation and industrial upgrading.

The communication platform provided by the forum, especially the precise docking function of booth D03, helps technology companies like Bono Biotech to accurately grasp market demand, optimize product development direction, and better serve the biopharmaceutical industry.

---

With the rapid development of the biopharmaceutical industry, the BIONNOVA forum has become an industry benchmark and connector. It is reported that the BIONNOVA series of forums also includes the Biomedical Innovator Forum and Exhibition held in Shanghai every April, as well as the first Λ esnova Medical Aesthetics Innovator Forum to be held in Shanghai on December 2-3.

In the future, Shanghai Bono Biotechnology Co., Ltd. will continue to deeply cultivate the field of biopharmaceutical technology, participate in industry exchanges through continuous innovation, and contribute its own strength to the development of China's biopharmaceutical industry.